Table 3.
Patients’ clinical follow-up after surgery grouped by their survival status.
| Survival free: 3 patients | Local recurrence after surgery: 11 patients | Metastatic recurrence: 6 patients | |
|---|---|---|---|
| Age | (15–87) years | (12–84) years | (34–80) years |
| Median age | 34 years | 42.33 years | 60 years |
| Site | |||
| Upper limb | 2 | 0 | 2 |
| Lower limb | 0 | 5 | 3 |
| Abdominal wall | 1 | 1 | 0 |
| Thorax | 0 | 1 | 0 |
| Head | 0 | 1 | 1 |
| Retroperitoneum | 0 | 1 | 0 |
| Inguinal | 0 | 2 | 0 |
| Tumor size (cm) | 3–15 | 3–12 | 4.5–16 |
| Mean size | 9 | 8 | 9 |
| Grade | |||
| Grade 1 | 1 | 2 | 0 |
| Grade 2 | 2 | 3 | 2 |
| Grade 3 | 0 | 6 | 4 |
| Stage | |||
| Ia | 1 | 0 | 0 |
| Ib | 0 | 0 | 0 |
| IIa | 0 | 1 | 2 |
| IIb | 1 | 7 | 1 |
| III | 1 | 3 | 3 |
| IV | 0 | 0 | 1 |
| Treatment | |||
| Surgery | 3 | 11 | 6 |
| Radiotherapy | 1 | 4 | 2 |
| Chemotherapy | 1 | 4 | 1 |
| Margin status | |||
| Wide | 2 | 0 | 0 |
| Intralesional | 0 | 5 | 1 |
| Marginal | 1 | 6 | 5 |
| Follow-up time (months) | 84–148 | 4–172 | 7–29 |
| Median | 116 | 42.95 | |
| Outcome | |||
| Survival (5 years) | 3 | 4 | 0 |
| Deaths (5 years) | 0 | 7 | 6 |
| Mean survival time (months) | 153 | 62 | 16 |